Nine price cervical cancer vaccine sprint mainland listing: US companies submit applications for acceptance

category:Global
 Nine price cervical cancer vaccine sprint mainland listing: US companies submit applications for acceptance


In April 24th, the news reporters on the website of the national drug review center of the national food and drug administration were inquiring. The application of the nine price HPV vaccine submitted by the United States pharmaceutical company has been accepted in April 20th, and the current state of the drug administration is review and approval. Cervical cancer is the only malignant tumor of the female reproductive tract after ovarian cancer. Nearly 600 thousand new cases occur worldwide each year, and about 300 thousand die. In China, about 135 thousand new cases are added each year, of which 80 thousand die. 99.7% of cervical cancer is caused by HPV virus infection. Public information shows that the nine price HPV vaccine of Mercedes, which was approved in the United States in 2014, is 9-26 years old, and the vaccine can prevent 90% of the cervical cancer virus. The nine price of Mercedes in Mercedes was approved in China in November 2017, and it took less than half a year to receive the application. In 2006, Hongkong became the first area to open cervical cancer vaccine in China. Until last year, the cervical cancer vaccine began to be officially launched in the mainland of China. The products listed on the mainland are the hili two price vaccine produced by British GlaxoSmithKline and the Mercedes gavavo tetravalent vaccine, while Hongkong is more popular than merschons nine price product. The price represents the coverage of the virus. The higher the price, the more virus coverage the virus has, the better the vaccine is. Persistent infection of high-risk HPV is the main cause of cervical cancer. HPV is the DNA virus of papillomavirus. It is the sole human host. The most favorite place is skin and mucous membrane. Studies have shown that there are 15 high-risk types of HPV, especially those of 16 and 18, which can cause cervical cancer precancerous lesions and cervical cancer. The HPV two valent vaccine can prevent 16 and 18 two kinds of HPV viruses; HPV tetravalent vaccines can be used to prevent 6, 11, 16, 18 HPV subtypes, and the HPV9 valence vaccine adds 31, 33, 45, 52 and 58 HPV virus subtypes on the basis of the original tetravalent, and the coverage of the virus is also reached. This led to an endless stream of mainland tourists coming to Hongkong for a long time. Fangzheng Securities Research Report analysis pointed out that the prevention of cervical cancer market, at least ten billion market. Nearly 2 million people were vaccinated every year in Hongkong. Some experts expect to add 8 million women to about 16000000 of the population every year, assuming that 50% of the vaccination of cervical cancer can bring about 4 billion yuan per year after the market is stable. However, the nine price of the brand will be officially listed in the mainland, and the final review and approval of the regulatory authorities will be required. Previously, Professor Wei Lihui, a well-known gynecologist in Peking University Peoples Hospital, said that the two price and four price vaccines were almost no different from the prevention effect of cervical cancer. For the target population, vaccination should be carried out as soon as the inoculation condition is available. Do not wait for the best vaccination time. The source of this article: surging news editor: Zhang Haitong _NN9053 However, the nine price of the brand will be officially listed in the mainland, and the final review and approval of the regulatory authorities will be required. Previously, Professor Wei Lihui, a well-known gynecologist in Peking University Peoples Hospital, said that the two price and four price vaccines were almost no different from the prevention effect of cervical cancer. For the target population, vaccination should be carried out as soon as the inoculation condition is available. Do not wait for the best vaccination time.